438a8c72 38e5 4d31 A2b0 418c6366ecbd 01
Mesalamine Tablet, Delayed Release
Product Images NDC 68382-711
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 68382-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
438a8c72 38e5 4d31 A2b0 418c6366ecbd 02
This is a medication for which NDC code is 68382-711-19. It is a delayed-release tablet containing 1.2g of Mesalamine, USP. The recommended dosage can be found in the package insert. It is to be stored at a temperature of 20°C to 25°C (68°F to 77°F). It should be dispensed in a light-resistant container and kept out of children's reach. The manufacturer is Haly and distributed by Zydus Pharmaceuticals (USA) Inc. The product comes in a bottle containing 120 tablets and is available only by prescription.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
